FH ORTHO
9
3
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
22.2%
2 terminated/withdrawn out of 9 trials
33.3%
-53.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Observational Study Conducted on Patients Receiving the ESOP 2 Stem to Confirm Security and Performance of the Device
Role: lead
Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices.
Role: lead
Performance and Safety Evaluation of the FHK®-CK Knee Prosthesis
Role: lead
FH ORTHO Shoulder Observatory
Role: lead
Observational Study to Evaluate Safety and Performance of the Total Ankle Prosthesis, EasyMove®
Role: lead
Study Conducted on Patients Operated With a FHK ASYMETRIQUE to Confirm Security and Performance of the Device
Role: lead
FH ORTHO SAS Knee Observatory
Role: lead
A Clinical Study Carried Out in Patients Operated With Calcanail®
Role: lead
Measurement of the Quality of Life in Patients Operated With a Total Knee Prosthesis (TKA) From the FHK® Range.
Role: lead
All 9 trials loaded